Related Experiment Video
Updated: Jul 2, 2026

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
Infant Renal Replacement Therapy Using Carpediem: A Multicenter Observational Cohort Study from the ICONIIC Learning
Cara L Slagle1, Kim T Vuong2, Kelli A Krallman3
1Division of Neonatology, Riley Hospital for Children at Indiana University Health and Indiana University College of Medicine, Indianapolis, IN; Neonatology and Pulmonary Biology, Cincinnati Children's Hospital Medical Center & University of Cincinnati College of Medicine, Cincinnati, OH; Center for Acute Care Nephrology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Insights
Survival for infants receiving continuous renal replacement therapy (CRRT) with the Carpediem system exceeded 60% in a US study. The primary use of CRRT was for end-stage kidney disease (ESKD) in infants.
Area of Science:
- Pediatric Nephrology
- Critical Care Medicine
- Medical Devices
Background:
- Continuous renal replacement therapy (CRRT) is crucial for critically ill infants with kidney dysfunction.
- The Carpediem system is the first infant-specific CRRT platform approved in the US.
- Evaluating its real-world use and outcomes is essential for optimizing pediatric critical care.
Purpose of the Study:
- To assess the indications for using the Carpediem system in infants.
- To evaluate the clinical outcomes, including survival, associated with Carpediem use.
- To analyze CRRT treatment courses and patient characteristics in a US cohort.
Main Methods:
- A multicenter observational study (retrospective and prospective) was conducted across four US centers.
- Data were collected on infants undergoing CRRT using the Carpediem system.
- Infant cohorts were categorized by CRRT indication: end-stage kidney disease (ESKD) and non-ESKD.
Main Results:
- Sixty-seven infants underwent 93 treatment courses with the Carpediem system.
- The primary indication for CRRT was ESKD (54%), followed by acute kidney injury (43%).
- Hospital discharge survival was 67% for ESKD and 60% for non-ESKD infants.
Conclusions:
- Carpediem facilitates CRRT in infants, with survival rates exceeding 60% in this US cohort.
- ESKD as a bridge to dialysis was the most common indication for CRRT in this population.
- The findings support the utility of Carpediem in managing critically ill infants requiring renal support.
Objective:
To evaluate indications and outcomes of Carpediem as the first infant-specific continuous renal replacement therapy (CRRT) platform available for clinical use in the US.
Study Design:
A multicenter, retrospective, and prospective observational study was conducted through the "Improving CRRT Outcomes in Neonates and Infants through Interdisciplinary Collaboration" Learning Network. Data were collected from the first four US centers utilizing Carpediem. A treatment course was defined as sequential CRRT procedures separated by ≤72 hours. Infant cohorts were categorized by CRRT indication: end-stage kidney disease (ESKD) (ie, CRRT as a bridge to peritoneal dialysis) and non-ESKD (all other indications).
Results:
Sixty-seven infants underwent 93 treatment courses using 1538 filters and 112 vascular access catheters. The primary indication for CRRT was ESKD in 36 (54%) and acute kidney injury in 43%. Median age at first treatment was 18 (IQR: 6, 81) days, and dry weight was 2.6 (IQR: 2.4, 3.1) kg for the ESKD cohort and 32 (IQR: 9, 90) days and 3.4 (IQR: 3.2, 4.5) kg for the non-ESKD cohort. Median treatment course duration was 12 (IQR: 3, 24) days for ESKD compared with 4 (IQR: 1, 13) days for non-ESKD infants. Survival for hospital discharge was 67% in ESKD and 60% in non-ESKD.
Conclusions:
In this US cohort study, CRRT survival in infants treated with Carpediem exceeds 60%. More than one-half of the treatment indications were for ESKD as a bridge to dialysis.
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care

